Alterity Therapeutics (ATHE) Free Cash Flow (2009 - 2020)
Alterity Therapeutics' (ATHE) quarterly Free Cash Flow came in at -$6.2 million in Q2 2020, up 36.76% year-on-year from -$4.5 million in Q3 2019, and down 448.91% quarter-over-quarter from $1.8 million in Q4 2019.
Alterity Therapeutics (ATHE) Free Cash Flow (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Free Cash Flow history runs 10 years deep, the most recent figure standing at -$6.2 million for Q2 2020.
- On a quarterly basis, Free Cash Flow rose 36.76% year-over-year to -$6.2 million in Q2 2020; TTM through Dec 2021 was -$6.2 million, a 56.42% increase from a year earlier, with the FY2025 full-year figure at -$7.3 million, up 11.76% from the prior year.
- Free Cash Flow eased to -$6.2 million in Q2 2020 per ATHE's latest filing, from $1.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $1.8 million in Q4 2019 and bottomed at -$9.8 million in Q2 2019.
- The 5-year median for Free Cash Flow is -$4.4 million (2017), against an average of -$3.4 million.
- Biggest YoY gain for Free Cash Flow was 134.21% in 2019; the steepest drop was 20575.33% in 2019.
- Year by year, Free Cash Flow stood at -$449190.3 in 2016, then slumped by 100.19% to -$899256.0 in 2017, then sank by 475.87% to -$5.2 million in 2018, then jumped by 134.21% to $1.8 million in 2019, then sank by 448.91% to -$6.2 million in 2020.
- Per Business Quant, the three latest ATHE Free Cash Flow figures stand at -$6.2 million (Q2 2020), $1.8 million (Q4 2019), and -$9.8 million (Q2 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -6.18 Mn |
| Jun 30, 2020 | -6.18 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Jun 30, 2018 | -47,278.38 |
| Jun 30, 2018 | -47,278.38 |
| Dec 31, 2017 | -899,256.01 |
| Dec 31, 2017 | -899,256.01 |
| Jun 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.41 Mn |
| Dec 31, 2016 | -449,190.35 |
| Dec 31, 2016 | -449,190.35 |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2016 | -5.54 Mn |
| Dec 31, 2014 | 31,228.39 Bn |
| Dec 31, 2014 | 31,228.39 Bn |